- Home
- PLMR vs AAPG Comparison
PLMR vs AAPG Comparison
Compare PLMR & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLMR | AAPG |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PLMR | AAPG |
|---|---|---|
| Price | $122.90 | $25.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $156.29 | $48.50 |
| AVG Volume (30 Days) | ★ 186.7K | 3.9K |
| Earning Date | 02-11-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.73 | N/A |
| EPS | ★ 6.40 | N/A |
| Revenue | ★ $778,362,000.00 | $54,524,554.00 |
| Revenue This Year | $270.49 | N/A |
| Revenue Next Year | $20.27 | $368.64 |
| P/E Ratio | $19.30 | ★ N/A |
| Revenue Growth | ★ 54.59 | N/A |
| 52 Week Low | $104.47 | $17.09 |
| 52 Week High | $175.85 | $48.45 |
Technical Indicators
Market Signals| Indicator | PLMR | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 33.57 |
| Support Level | $119.43 | $25.52 |
| Resistance Level | $130.81 | $26.30 |
| Average True Range (ATR) | 4.48 | 0.57 |
| MACD | -1.08 | -0.12 |
| Stochastic Oscillator | 23.89 | 0.00 |
Price Performance
Historical ComparisonAbout PLMR Palomar Holdings Inc.
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.